Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 6;37(34):3243–3255. doi: 10.1200/JCO.19.00919

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by American Society of Clinical Oncology

PMC Copyright notice

FIG 2. — (A) Event-free survival (EFS) and overall survival (OS) for evaluable, intermediate-risk patients (n = 404). (B) EFS for evaluable, intermediate-risk patients according to initial treatment group assignment (n = 404; P = .0012). (C) OS for evaluable, intermediate-risk patients according to initial treatment group assignment (n = 404; P < .001). (D) EFS for evaluable, intermediate-risk patients according to 1p loss of heterozygosity (LOH) status (n = 341; P = .41). (E) OS for evaluable, intermediate-risk patients according to 1p LOH status (n = 341; P = .44). (F) EFS for evaluable, intermediate-risk patients according to 11q LOH status (n = 340; P = .02). (G) OS for evaluable, intermediate-risk patients according to 11q LOH status (n = 340; P = .09).